Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,591.90
(
0.54%
)
US TECH 100
23,454.40
(
0.41%
)
Dow Jones
46,429.49
(
0.66%
)
Brent Oil
98.72
(
-0.06%
)
Bitcoin
71,168.89
(
-0.19%
)
News Focus
News Focus
Post# of 257286
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 49
Posts 5519
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 100691

Wednesday, 08/04/2010 8:15:30 PM

Wednesday, August 04, 2010 8:15:30 PM

Post# of 257286
i think TEVA should make an offer for MNTA (seriously)

the 45% share of lovenox profits with duopoly pricing is probably worth more than what TEVA's generic would bring in as a 3rd or 4th generic assuming they even get approval. and the copaxone headaches go away

that would be 2B well spent
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today